Breast cancer resistance protein expression and resistance to daunorubicin in blast cells from patients with acute myeloid leukaemia.
about
Modulating drug resistance by targeting BCRP/ABCG2 using retrovirus-mediated RNA interferenceCharacterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation.Are MTT assays the right tool to analyze drug resistance caused by ABC-transporters in patient samples?The liposomal daunorubicin plus tamoxifen: improving the stability, uptake, and biodistribution of carriers.The challenge of exploiting ABCG2 in the clinic.Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction.Assessment of drug resistance in acute myeloid leukemia.The emerging pharmacotherapeutic significance of the breast cancer resistance protein (ABCG2).Role of the breast cancer resistance protein (ABCG2) in drug transport.Modulation of oral drug bioavailability: from preclinical mechanism to therapeutic application.Quantum-SAR extension of the spectral-SAR algorithm: application to polyphenolic anticancer bioactivityABCG2: the key to chemoresistance in cancer stem cells?An experimental approach to evaluate the impact of impaired transport function on hepatobiliary drug disposition using Mrp2-deficient TR- rat sandwich-cultured hepatocytes in combination with Bcrp knockdown.Human ABCG2: structure, function, and its role in multidrug resistance.ABCG2 inhibition as a therapeutic approach for overcoming multidrug resistance in cancer.Prediction of Therapy Response and Prognosis in Leukemias by Flow Cytometric MDR Assays.Is ATP binding responsible for initiating drug translocation by the multidrug transporter ABCG2?Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and function.Flow cytometry-based approach to ABCG2 function suggests that the transporter differentially handles the influx and efflux of drugs.ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.Effects of Hypoxia on Biology of Human Leukemia T-cell Line (MOLT-4 cells) Co-cultured with Bone Marrow Mesenchymal Stem Cells.
P2860
Q28541362-B8A0A4EE-9099-44A9-A9A7-CDA252EAC8EEQ33184830-39B38E95-BE67-4D33-8235-5BD38FB17BB4Q33221958-961F0051-9AD9-4421-A23B-F0182AA235DFQ34201358-DC2D50D2-183F-4196-B139-3768F26A9853Q34968909-E4F44F45-8770-47EB-AEB2-42E23667984FQ35848938-5C505541-386D-4048-B64E-095B3976EA03Q35878296-B60C42C6-6665-4DF7-BE5F-91E311F80E46Q36052743-8D7E3305-771B-4353-9C21-A0FFEFF8B8BAQ36250753-76522168-F320-41E1-ACCD-78747CE012B5Q36271954-F852FA47-F58A-4C70-9265-F329D14BA350Q37166328-7539C479-896C-4156-8F91-79465615033BQ37587219-8479E9E6-016F-4B49-A4A2-8E2DD1CF47B8Q37714185-45B2DF3E-5758-4D81-9635-12AA52316286Q38003156-D33AD501-C705-4F65-93B5-669940E4A363Q38848383-010A01CF-0891-41B1-955B-559C8E976695Q39341118-14CCA596-4964-4BCD-BC67-D47319EB7741Q39957087-CA435577-BC37-4A27-A823-E8B0748563A7Q40543176-6EBF6CCE-C0F1-492A-8F06-2BA9D461AF21Q42166480-248B3A10-9FD1-4395-B4EB-FB260299F2C1Q45918795-F7A41FE6-C268-4685-9A3A-A0AAB3917840Q55013035-70EB9341-8C1C-4AB8-A8FD-742101885DB7
P2860
Breast cancer resistance protein expression and resistance to daunorubicin in blast cells from patients with acute myeloid leukaemia.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Breast cancer resistance prote ...... with acute myeloid leukaemia.
@en
Breast cancer resistance prote ...... with acute myeloid leukaemia.
@nl
type
label
Breast cancer resistance prote ...... with acute myeloid leukaemia.
@en
Breast cancer resistance prote ...... with acute myeloid leukaemia.
@nl
prefLabel
Breast cancer resistance prote ...... with acute myeloid leukaemia.
@en
Breast cancer resistance prote ...... with acute myeloid leukaemia.
@nl
P2093
P2860
P1476
Breast cancer resistance prote ...... with acute myeloid leukaemia.
@en
P2093
C G Taylor
C J Williamson
J M Sargent
M Maliepaard
R J Scheper
P2860
P304
P356
10.1046/J.1365-2141.2001.03122.X
P407
P577
2001-11-01T00:00:00Z